Transgenic expression of osteoactivin in the liver attenuates hepatic fibrosis in rats

Biochemical and Biophysical Research Communications

Volumn 356, Issue 3, 2007, Pages 610-615

  Abe, Hiroo ^a   Uto, Hirofumi ^b   Takami, Yoichiro ^c   Takahama, Yuka ^c   Hasuike, Satoru ^a   Kodama, Mayumi ^a   Nagata, Kenji ^a   Moriuchi, Akihiro ^b   Numata, Masatsugu ^d   Ido, Akio ^d   Tsubouchi, Hirohito ^b,d  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c Miyazaki Prefectural Industrial Support Foundation   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Choline deficient l amino acid defined diet; Hepatic fibrosis; Osteoactivin; PDGF receptor; TIMP

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; CHOLESTEROL; COLLAGEN TYPE 1; GLUCOSE; LACTATE DEHYDROGENASE; METALLOPROTEINASE; METALLOPROTEINASE 1; METALLOPROTEINASE 2; OSTEOACTIVIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FIBROGENESIS; GENE EXPRESSION REGULATION; LIVER FIBROSIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSGENIC RAT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CHOLINE DEFICIENCY; GENE EXPRESSION PROFILING; GENE THERAPY; LIVER; LIVER CIRRHOSIS; MEMBRANE GLYCOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

RATTUS;

EID: 33947644287     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.035     Document Type: Article

References (22)

1. Guerret S., Desmoulière A., Chossegros P., Costa A.M., Badid C., Trépo C., Grimaud J.A., and Chevallier M. Long-term administration of interferon-alpha in non-responder patients with chronic hepatitis C: follow-up of liver fibrosis over 5 years. J. Viral. Hepat. 6 (1999) 125-133
2. Ueberham E., Löw R., Ueberham U., Schönig K., Bujard H., and Gebhardt R. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology 37 (2003) 1067-1078
3. George J., Roulot D., Koteliansky V.E., and Bissell D.M. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. Proc. Natl. Acad. Sci. USA 96 (1999) 12719-12724
4. Borkham-Kamphorst E., Herrmann J., Stoll D., Treptau J., Gressner A.M., and Weiskirchen R. Dominant-negative soluble PDGF-beta receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis. Lab. Invest. 84 (2004) 766-777
5. Nakae D., Yoshiji H., Mizumoto Y., Horiguchi K., Shiraiwa K., Tamura K., Denda A., and Konishi Y. High incidence of hepatocellular carcinomas induced by a choline deficient l-amino acid defined diet in rats. Cancer Res. 52 (1992) 5042-5045
6. Safadi F.F., Xu J., Smock S.L., Rico M.C., Owen T.A., and Popoff S.N. Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts. J. Cell Biochem. 84 (2001) 12-26
7. Shikano S., Bonkobara M., Zukas P.K., and Ariizumi K. Molecular cloning of a dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparan sulfate proteoglycans. J. Biol. Chem. 276 (2001) 8125-8134
8. Onaga M., Ido A., Hasuike S., Uto H., Moriuchi A., Nagata K., Hori T., Hayash K., and Tsubouchi H. Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, l-amino acid-defined diet, accelerates motility of hepatoma cells. J. Hepatol. 39 (2003) 779-785
9. Toyonaga T., Hino O., Sugai S., Wakasugi S., Abe K., Shichiri M., and Yamamura K. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc. Natl. Acad. Sci. USA 91 (1994) 614-618
10. López-De León A., and Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J. Histochem. Cytochem. 33 (1985) 737-743
11. Yoshiji H., Kuriyama S., Yoshii J., Ikenaka Y., Noguchi R., Nakatani T., Tsujinoue H., and Fukui H. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34 (2001) 745-750
12. Woessner J.F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch. Biochem. Biophys. 93 (1961) 440-447
13. Lockhart D.J., Dong H., Byrne M.C., Follettie M.T., Gallo M.V., Chee M.S., Mittmann M., Wang C., Kobayashi M., Horton H., and Brown E.L. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14 (1996) 1675-1680
14. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., Coller H., Loh M.L., Downing J.R., Caligiuri M.A., Bloomfield C.D., and Lander E.S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286 (1999) 531-537
15. Haralanova-Ilieva B., Ramadori G., and Armbrust T. Expression of osteoactivin in rat and human liver and isolated rat liver cells. J. Hepatol. 42 (2005) 565-572
16. Ogawa T., Nikawa T., Furochi H., Kosyoji M., Hirasaka K., Suzue N., Sairyo K., Nakano S., Yamaoka T., Itakura M., Kishi K., and Yasui N. Osteoactivin upregulates expression of MMP-3 and MMP-9 in fibroblasts infiltrated into denervated skeletal muscle in mice. Am. J. Physiol. Cell Physiol. 289 (2005) C697-C707
17. Mochida S., Yoshimoto T., Mimura S., Inao M., Matsui A., Ohno A., Koh H., Saitoh E., Nagoshi S., and Fujiwara K. Transgenic mice expressing osteopontin in hepatocytes as a model of autoimmune hepatitis. Biochem. Biophys. Res. Commun. 317 (2004) 114-120
18. Cicognani C., Malavolti M., Morselli-Labate A.M., Zamboni L., Sama C., and Barbara L. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch. Intern. Med. 157 (1997) 792-796
19. Pinzani M., Milani S., Herbst H., DeFranco R., Grappone C., Gentilini A., Caligiuri A., Pellegrini G., Ngo DV., Romanelli R.G., and Gentilini P. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am. J. Pathol. 148 (1996) 785-800
20. Wong L., Yamasaki G., Johnson R.J., and Friedman S.L. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J. Clin. Invest. 94 (1994) 1563-1569
21. Breitkopf K., Roeyen C., Sawitza I., Wickert L., Floege J., and Gressner A.M. Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors alpha and beta in activated rat hepatic stellate cells (HSC). Cytokine 31 (2005) 349-357
22. Isogai Z., Ono R.N., Ushiro S., Keene D.R., Chen Y., Mazzieri R., Charbonneau N.L., Reinhardt D.P., Rifkin D.B., and Sakai L.Y. Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J. Biol. Chem. 278 (2003) 2750-2757